Aug 12, 2020
Phio Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
Jun 22, 2020
Phio Presents Additional Data Supporting Potential of TIGIT Targeting INTASYL Compound in the Tumor Microenvironment at AACR 2020
Jun 19, 2020
TechAccel Subsidiary RNAissance Ag Completes Acquisition of St. Louis-based RNAgri
Jun 17, 2020
Sirnaomics and Precision NanoSystems Have Formed a Partnership
Jun 11, 2020
Sirnaomics Announces Decision to Spin off RNAimmune to Develop Novel mRNA Therapeutics and Vaccines
Jun 09, 2020
Evox Therapeutics Announces a Multi-target RNAi and Antisense Research Collaboration and License Agreement With Lilly
Jun 08, 2020
Phio Pharmaceuticals to Host Key Opinion Leader Call on Intratumoral Therapy with Self-Delivering RNAi on Friday, June 12th
May 29, 2020
Phio Announces Positive In Vivo Data on the Intratumoral Use of INTASYL Compounds Showing Strong Antitumor Activity
May 27, 2020
DiamiR Receives USPTO Notice of Allowance For Key Patent Covering the Use of Circulating Brain-Enriched microRNA Biomarkers for Monitoring of Brain Aging; Provides Update on Its Patent Portfolio
Mar 26, 2020
Phio Pharmaceuticals Reports Year End 2019 Financial Results and Provides Business Update
Mar 24, 2020
AI-Derived COVID-19 Experimental Data and Reagent Insights Now Available From BenchSci to Accelerate R&D Efforts
Feb 10, 2020
Phio Pharmaceuticals Announces Compliance with Nasdaq Listing Requirements
Jan 24, 2020
Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV
Nov 21, 2019
Phio Pharmaceuticals and Karolinska Institutet Expand Collaboration to Develop Self-Delivering RNAi Immunotherapies for Treating Solid Tumors
Nov 06, 2019
Sirnaomics to Present Overview of Company's RNAi Technology Platform at Upcoming Conferences
Oct 31, 2019
Sirnaomics to Present Preclinical STP705 Data Suggesting Reduction in Liver Fibrosis at AASLD Liver Meeting
Oct 31, 2019
Appendix 4C: Quarterly Cash Flow Report
Oct 29, 2019
Phio Pharmaceuticals to Highlight Self-delivering RNAi Technology at SITC 2019
Oct 14, 2019
Global RNA Interference (RNAi) Industry
Oct 09, 2019
Sirnaomics' President and CEO Patrick Lu to Give Keynote Address at RNAi China Conference